Press-center

  • Acute issues of drug supply of the country will be discussed in Kaliningrad 15 September 2020

    Acute issues of drug supply of the country will be discussed in Kaliningrad

    The partnering "Medicines of Russia - for an interdisciplinary dialogue" will take place on September 25 in Kaliningrad. The focus is on the results of the implementation of the Pharma 2020 strategy, the modernization of the drug supply system, pilot projects for drug reimbursement, the availability and safety of drugs, fair competition in the pharmaceutical market. Now, these and other issues will be discussed at the meeting in the amber capital and online by heads of federal and regional authorities, leading experts of the pharmaceutical industry, managers and specialists of pharmaceutical industries, representatives of professional associations and communities.

  • Open letter to the Federal Antimonopoly Service of Russia 20 August 2020

    Open letter to the Federal Antimonopoly Service of Russia

    Dear Colleagues!

    (And we, at least, are united by our long-term professional work as part of the expert council under the Federal Antimonopoly Service (FAS) for the Development of Competition in the Social Sphere and Healthcare.)


  • Labeling - a step forward or stagnation? 21 July 2020

    Labeling - a step forward or stagnation?

    There is a threat of a lack of drugs in Russia, said experts of the round table "Labeling of Medicines" on the air of the radio "Komsomolskaya Pravda". Since July 1, the mandatory labeling of drugs has started, but manufacturers will soon be able to obtain permission from the interdepartmental commission and produce drugs without labeling until October 1. While some companies are waiting for permission, others are faced with technical failures and many hours of downtime when using the system under load. The lack of a clear understanding of the situation and jointly developed actions and solutions in a particular situation between government agencies and the pharmaceutical industry does not give positive results.

  • It is necessary to raise the degree of confidence in labeling 06 July 2020

    It is necessary to raise the degree of confidence in labeling

    On July 1, compulsory labeling of medicines began. On the same day, the industry learned about Government Decision No. 955, signed on the eve, “On the Peculiarities of Putting Medicines into the Civil Circuit for Medical Use”. Despite the numerous appeals of industry associations to the authorities, their fears about problems with the launch of the system and a possible lack of drugs  are still left without proper attention and the Resolution did not remove all the issues of the industry.

  • Labeling started. What is next? 01 July 2020

    Labeling started. What is next?

    From July 1, 2020, labeling of drugs becomes mandatory in Russia. However, no one gives guarantees of its uninterrupted operation, especially since the industry announced that it was not ready to start. The State Duma has prepared amendments to Federal Law No. 61 “On the Circulation of Medicines,” which should give the government the right to postpone the introduction of mandatory labeling of medicines in full. In the near future, they will be discussed in the third reading.

  • From July 1, marking starts in manual mode 09 June 2020

    From July 1, marking starts in manual mode

    Around the introduction of mandatory labeling of drugs in Russia there has been controversy for several years. Today the situation has escalated. There will be no postponing of start labeling. The inter-factional working group on improving the legislation in the field of drug provision recommended the Government a safe entry into the system from July 1. The Ministry of Health assured the deputies that there would be no problems with drug provision.

  • The pharmaceutical industry asked Vladimir Putin to postpone labeling start for 2021 02 June 2020

    The pharmaceutical industry asked Vladimir Putin to postpone labeling start for 2021

    11 pharmaceutical industry organizations uniting drug manufacturers, distributors, pharmacy organizations, the patient community wrote a collective letter addressed to President of the Russian Federation Vladimir Putin, in which draw attention of the head of state to the unpreparedness to launch industrial operation of the drug movement monitoring (DMM) system and give arguments why it is necessary to postpone the start scheduled for July 1, 2020.

  • Fifty days before the start or how to live after July 1? 11 May 2020

    Fifty days before the start or how to live after July 1?

    Labeling of drugs starts on July 1, or again, for objective reasons, the start will be postponed? The issue of postponing the start of drug labeling is particularly acute in a pandemic when the uninterrupted and timely provision of drugs to patients is crucial. The pharmaceutical industry, while supporting and understanding the importance of introducing a labeling system, also notes the risks associated with the launch of a system that is not 100% ready. The world situation associated with the threat of the spread of coronavirus has led to quarantine restrictions, which negatively affects the ability to start the system on time.

  • Let's try to solve something that is easy to solve 24 April 2020

    Let's try to solve something that is easy to solve

    In the created difficult conditions, it is impermissible luxury not to use and doom quality and safe medicines to spoilage. The law enforcement practice of suspension of circulation of drugs due to the identification of comments on production is such that the drug waits for the resumption of circulation in the warehouse until the identified comments are eliminated. Correction of comments is confirmed by repeated (control) inspection of production. Today, on-site inspection has become impossible due to quarantine restrictions. Accordingly, drugs deprived of circulation are waiting for the expiration date getting "dusty" in warehouses. Is it right and prudent? Of course not, especially since patients who interrupted therapy suffer from this.

  • 17 April 2020

    ARPM: there are no interruptions in drug supply and will not be

    To date, there is no interruption in medication and is not expected. We have sufficient reserves of drugs and raw materials, all the necessary reserves have been created. This was announced on April 16 by the director general of the Association of Russian Pharmaceutical Manufacturers Victor Dmitriev at the online conference of Kommersant Publishing House “Latest pharmaceutical industry news and anti-virus investments”.

  • Government Decree No. 500 is the victory of common sense 16 April 2020

    Government Decree No. 500 is the victory of common sense

    On April 13, Government Decree No. 500 was issued, which temporarily suspended the previously issued 431 Decree. The industry perceived this as a victory of common sense. As early as April 7, the Association of Russian Pharmaceutical Manufacturers contacted the Ministry of Industry and Trade for clarification on the enforcement of the Government Decree of April 3, No. 431 “On establishing the characteristics of the circulation of medical devices ...

  • Patent fight under the covers 14 April 2020

    Patent fight under the covers

    Generic manufacturers are against linking patent protection with drug registration procedure. Experts are sure, protecting the interests of one, barriers are created for other market participants. The legislative initiative will have a negative impact on both the Russian healthcare system and the pharmaceutical industry as a whole.

  • 09 April 2020

    ARPM: pharmaceutical industry mobilized to fight COVID-19

    Russia is doing everything possible to curb the spread of COVID-19. At this difficult time, the leading pharmaceutical companies unite and direct all their efforts to the creation and production of medicines and vaccines that everyone needs so much now. The pharmaceutical industry takes all necessary steps to maintain production continuity and ensure uninterrupted supply of medicines for patients both in Russia and the EAEU countries, and in countries that have applied for help to Russia.

  • Velfarm is a member of the Association of Russian Pharmaceutical Manufacturers 06 April 2020

    Velfarm is a member of the Association of Russian Pharmaceutical Manufacturers

    The Association of Russian pharmaceutical manufacturers is replenishing its ranks. In accordance with the decision of the ARPM general meeting, the company Velpharm LLC (BRIGHT WAY group of companies) became a new member. The company noted that they are optimistic about joining the ranks of the Association, which unites leading Russian pharmaceutical companies.
    Velfarm LLC is a Russian full-cycle pharmaceutical manufacturer that creates modern, effective, safe and affordable medicines.

  • 23 March 2020

    100 days before collapse

    Labeling of medicines is one of the most ambitious and discussed issues in the pharmaceutical industry. The entire pharmaceutical industry supports its introduction, but during the experiment, participants are faced with many problems that perplex not only the performers, but also the organizers of the project. In particular, manufacturers do not understand how to deal with a pandemic. Foreign specialists cannot come to production facilities for commissioning of the equipment, and Russian specialists cannot go abroad for testing and training. How do the experiment participants feel 100 days before the official launch of the drug labeling project?

  • Will coronavirus send labeling to quarantine? 19 March 2020

    Will coronavirus send labeling to quarantine?

    The Association of Russian Pharmaceutical Manufacturers sent a letter addressed to the Chairman of the State Duma of the Russian Federation Vyacheslav Volodin with a request to introduce a stop time for the period of restrictive quarantine measures for the introduction of drug labeling from July 1.
    Manufacturers contact the Association because of difficulties encountered in preparing for the launch of the mandatory drug labeling system.

  • ARPM: no need to escalate the situation 16 March 2020

    ARPM: no need to escalate the situation

    Prime Minister Mikhail Mishustin instructed to expedite the adoption of a bill that allows the remote sale of OTC (over-the-counter) drugs and their delivery due to an increase in the number of patients with coronavirus in the country. The State Duma may pass the law on selling drugs on the Internet on Thursday, March 19, Andrei Isaev, the first deputy head of the United Russia faction in the State Duma, announced this to REGNUM.

  • The common drug market in the EAEU is in the center of attention of pharmaceutical industry experts 12 March 2020

    The common drug market in the EAEU is in the center of attention of pharmaceutical industry experts

    “The functioning of the unified market for medicines of the Eurasian Economic Union” is the topic of a round table that will be held on April 7 as part of the XII scientific-practical conference “State regulation and the pharmaceutical industry”. The main issues of law enforcement requiring priority attention will be discussed by representatives of the EEC and authorized bodies of the countries of the Eurasian Economic Union with leading experts in the pharmaceutical industry.

  • We still have 116 days left ?! 05 March 2020

    We still have 116 days left ?!

    Starting March 1, all participants must be registered in the state drug movement monitoring (DMM) system. It is assumed that their information systems are already on alert for interaction with the state information system "DMM". To date, the most prepared link in the entire distribution chain are pharmaceutical manufacturers. But in the industry, there are still representatives of pharmacies and medical institutions who ask: what is labeling? Meanwhile, 116 days are left before the start. July 1, 2020 the law comes into force.

  • Interchangeability in Russia was, is and will be 02 March 2020

    Interchangeability in Russia was, is and will be

    The round table “Interchangeability of medicines” was held on the initiative of the Association of Russian Pharmaceutical Manufacturers in the press center of the publishing house “Komsomolskaya Pravda”. The discussion of the amendments adopted at the end of 2019 in 61-FL “On Circulation of Medicines” was joined by: the Federal Antimonopoly Service, the medical and patient communities, manufacturers and market experts. All parties have their own questions to the implementation of the rule of law.


News 1 - 20 from 212
First page | Prev. | 1 2 3 4 5 | Next | Last page